A Florida pharmacy that opens a PBM audit notice is operating under one state chapter that does two jobs, plus a federal overlay that can narrow both. The Florida Office of Insurance Regulation licenses the PBM under one statute, while a second statute in the same chapter controls how any PBM, insurer, or health maintenance organization conducts the audit. ERISA and Medicare Part D then decide how far the state rules reach, depending on the health plan behind the claims being audited.
The Office of Insurance Regulation's Authority Over PBMs
The Office of Insurance Regulation has registered PBMs doing business in Florida since the requirement took effect on January 1, 2019, under Section 624.490 of the Florida Statutes. A PBM must submit a nonrefundable fee of up to $500, its corporate charter, and a registration form naming its officers and directors, and the resulting certificate is valid for two years. A PBM that operates without registering is subject to a fine of $10,000 for each violation. That authority governs who may act as a PBM in the state, separate from the audit procedure rules in Section 624.491 that apply once a PBM examines a pharmacy's claims.
Florida's Pharmacy Audit Statute: Notice, Scope and Lookback
Section 624.491 governs the audit itself whenever a pharmacy benefits plan, or a PBM acting for one, examines records at a pharmacy licensed under Chapter 465. The entity conducting the audit must notify the pharmacy at least 7 calendar days before the initial onsite audit of each cycle, and cannot schedule that visit during the first three calendar days of a month unless the pharmacist agrees otherwise. The audit period itself cannot reach back more than 24 months from the date a claim was submitted or adjudicated, and a clinical audit has to be conducted by, or in consultation with, a pharmacist. The statute excludes audits built on suspected fraud, claims paid under federally funded programs, and desk reviews finished within three business days with no chargeback demanded. Even a routine refill-too-soon finding has to clear this notice and scope framework first.
Extrapolation, Recoupment and the Right to Appeal
The same statute controls what happens after the audit finds a problem. Any recoupment or penalty must be calculated from the pharmacy's actual overpayment, not from an extrapolated projection across the audit period. The entity must deliver a preliminary audit report within 120 days after the audit concludes, and the pharmacy then has 10 business days to produce documentation addressing a disputed finding before the final report issues within six months of that receipt. From there, a pharmacy's audit appeal runs through the Agency for Health Care Administration's claim dispute resolution program under Section 408.7057, filed within 12 months of the plan's final determination and reviewed within 90 days.
Florida law requires that any recoupment or penalty from a pharmacy audit be calculated from the pharmacy's actual, documented overpayment, never from an extrapolated projection across the audit period.
Where ERISA and Medicare Part D Limit Florida's Reach
Florida's audit statute does not reach every plan. In Rutledge v. Pharmaceutical Care Management Association, the Supreme Court held 8-0 in 2020 that ERISA does not preempt a state's cost regulation of PBMs, because rules of that kind do not force an ERISA plan to adopt any particular coverage design. Medicare Part D works differently. The Tenth Circuit held in 2023 that Part D's preemption clause functions close to field preemption, displacing state network and pricing rules for Part D plans, and the Supreme Court left that decision in place in 2025. Whether Florida's notice, lookback, and extrapolation protections apply turns on whether the claims behind the audit sit in a self-funded ERISA plan, a Part D plan, or neither.
Why Early Legal Counsel Is Critical
It is critical that Florida pharmacies promptly retain experienced healthcare defense counsel upon receiving a PBM audit notice, a preliminary audit report, or any related Office of Insurance Regulation inquiry. Early legal intervention can protect the pharmacy's rights, ensure an accurate and complete audit response, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with the PBM or the agency on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the pharmacy to recoupment exposure that proper handling could have avoided.
How Health Law Alliance Can Help
Health Law Alliance represents Florida pharmacies through PBM audits, from the first onsite notice through the appeal before the Agency for Health Care Administration.
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
If a Florida pharmacy has received a PBM audit notice or an unfavorable preliminary report, contact Health Law Alliance's Florida pharmacy audit defense team for a free, confidential consultation before the response window closes.
